Vin Sachidananda, PhD

Partner at Radical Ventures

📍 United States🔄 Updated September 2026💼 10 investments📅 8 years investing🗓 Last invested Jan 2026
VC🌍 United StatesInvested this year
10
Total investments
2
Early stage
3
Mid stage
0
Late stage
8y
Years active

Portfolio

9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer and Series B Investor
Jan 2026
Our efficient systems-level AI infrastructure enables a tenfold improvement in both training and inferencing of the largest generative models. Leveraging these capabilities, Decart is able to train its own foundational generative interactive models and make it accessible for everyone in real-time.
Series B Investor
Oct 2024
Iambic is a clinical-stage AI biotech developing novel medicines using its AI-driven platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with industry-leading speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets to address urgent unmet patient need. Learn more at iambic.ai
Pre-seed Investor
Jul 2024
Building the worlds fastest language models, powered by diffusion.
Board Observer and Investor
Jun 2024
Distributional is an open and free solution for analytics on production AI logs to understand, fix, and improve your AI products at scale. Install at https://docs.dbnl.com.
Series A Investor
May 2024
Frontier Inference Clusters
Seed Investor
Dec 2023
SDF is the next generation transformation layer and best developer platform for data. A compiler and execution engine designed to improve the data engineering experience, with compile time guarantees and composable execution. Join our community slack: https://lnkd.in/gpuCHKgF
Series A and B Investor
Aug 2023
Cerby is the identity automation platform purpose-built to secure disconnected applications—those that fall outside the reach of traditional identity security tools. By integrating with existing IAM, IGA, and PAM systems, Cerby brings centralized access controls, automates manual security tasks, and extends governance across your entire application ecosystem. IT and security teams gain complete visibility and control, reducing risk and operational overhead. Founded in 2020, Cerby is backed by leading investors and trusted by enterprises across the globe. Get a demo to see us in action: www.cerby.com/demo
Seed Investor
Apr 2023
A modern search platform that learns from human feedback. Say hi at hello@objective.inc
Board Observer and Investor
Apr 2023
One platform to build, test, and train anything
Experience · 13 entries
All (13)
Investments (10)
Board (3)
2026
Board Observer and Series B Investor
Jan 2026
Our efficient systems-level AI infrastructure enables a tenfold improvement in both training and inferencing of the largest generative models. Leveraging these capabilities, Decart is able to train its own foundational generative interactive models and make it accessible for everyone in real-time.
2025
Partner
Oct 2025
Radical Ventures is a venture capital firm investing in entrepreneurs applying deep technology to transform massive industries. With a primary focus on machine learning and artificial intelligence, Radical Ventures seeks to partner with exceptional entrepreneurs with global ambition to build enduring companies. Radical Ventures Radical has offices in Toronto and San Francisco, and partners in London and New York — and is backed by leading global investors.
2024
Series B Investor
Oct 2024
Iambic is a clinical-stage AI biotech developing novel medicines using its AI-driven platform. Based in San Diego and founded in 2020, Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters. The Iambic platform has demonstrated delivery of new drug candidates to human clinical trials with industry-leading speed and across multiple target classes and mechanisms of action. Iambic is advancing a pipeline of potential best-in-class and first-in-class clinical assets to address urgent unmet patient need. Learn more at iambic.ai
Pre-seed Investor
Jul 2024
Building the worlds fastest language models, powered by diffusion.
Board Observer and Investor
Jun 2024
Distributional is an open and free solution for analytics on production AI logs to understand, fix, and improve your AI products at scale. Install at https://docs.dbnl.com.
Show all 13 entries ↓
Investment activity
2018–2026 · 10 investments
20181202342024420261
Recent (last 2 years)Earlier